SOURCE-LINKED INTELLIGENCE

Engineering Synthetic Gene Circuits through Competitive Dimerization.

CORDIS · observation · Publication date unknown

design of MADTFs and ΔTFs not only facilitates their integration into a variety of biotechnological applications but also enhances their potential for clinical translation. Computational modeling and machine learning techniques will be employed to explore the design space of synthetic circuits based on these components, ensuring they meet desired regulatory functions. This framework will guide the experimental implementation of synthetic circuits in human cell lines. As a proof of concept, the therapeutic potential of DIMERCIRCUITS will be demonstrated in patient-derived organoids for the treatment of Friedreich's ataxia, a rare genetic neurodegenerative disorder. By engineering a gene dosage compensation circuit, DIMERCIRCUITS aims to achieve precise regulation of therapeutic gene expression within a narrow window, independent of viral vector uptake, thereby mitigating the overxpression-related toxicity risks associated with current gene therapy approaches. DIMERCIRCUITS aims to establish a foundational technology for precision-engineered synthetic circuits enabling transformative a

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

2484115

unit

EUR